Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Carbocysteine-lysine
2. S-carboxymethylcysteine-lys
3. Scmc-lys
1. 49673-81-6
2. (r)-2-amino-3-((carboxymethyl)thio)propanoic Acid (s)-2,6-diaminohexanoic Acid (1:1)
3. (r)-2-amino-3-((carboxymethyl)thio)propanoic Acid Compound With (s)-2,6-diaminohexanoic Acid (1:1)
4. 1d1y95pxxa
5. L-lysine, Compound With S-(carboxymethyl)-l-cysteine (1:1)
6. (2r)-2-amino-3-(carboxymethylsulfanyl)propanoic Acid;(2s)-2,6-diaminohexanoic Acid
7. (r)-2-amino-3-((carboxymethyl)thio)propanoic Acid,(s)-2,6-diaminohexanoic Acid
8. Unii-1d1y95pxxa
9. Einecs 256-425-9
10. Carbocisteine Lysine
11. Lysine Carbocysteinate
12. Schembl677472
13. Dtxsid60964336
14. Amy25318
15. Carbocisteine Lysine [mart.]
16. Carbocisteine Lysine [who-dd]
17. Lysine Carboxymethyl Cysteinate
18. Akos015907751
19. S-(carboxymethyl)cysteine--lysine (1/1)
20. Lysine Carboxymethyl Cysteinate [inci]
21. A827792
22. Q27252258
23. L-lysine, Compd. With S-(carboxymethyl)-l-cysteine (1:1)
24. 2-amino-3-(carboxymethylsulfanyl)propanoic Acid; 2,6-diaminohexanoic Acid
Molecular Weight | 325.38 g/mol |
---|---|
Molecular Formula | C11H23N3O6S |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 10 |
Exact Mass | 325.13075664 g/mol |
Monoisotopic Mass | 325.13075664 g/mol |
Topological Polar Surface Area | 215 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 267 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Date of Issue : 2022-06-24
Valid Till : 2025-07-02
Written Confirmation Number : WC-0102n
Address of the Firm :
Zhejiang Hengkang Pharm Group is a dynamic pharmaceutical entity, spanning drug research, large-scale production, and global marketing.
Date of Issue : 2023-01-18
Valid Till : 2025-01-17
Written Confirmation Number : ZJ230011
Address of the Firm :
L-Lysine-S-Carboxymethyl-L-Cysteine IH
Date of Issue : 2022-06-24
Valid Till : 2025-07-02
Written Confirmation Number : WC-0102n
Address of the Firm : Plot No. B5&B6, A1&A2, MEPZ-Tambaram, Chennai-600 045, India
Zhejiang Hengkang Pharm Group is a dynamic pharmaceutical entity, spanning drug research, large-scale production, and global marketing.
Date of Issue : 2023-01-18
Valid Till : 2025-01-17
Written Confirmation Number : ZJ230011
Address of the Firm : No.11 Chengen Road, Pubagang Town, Sanmen, Zhejiang, China 317100
About the Company : Axplora, created from the merger of Farmabios, Novasep & PharmaZell, is a leading API manufacturing partner to the world’s leading pharma & biotech companies, delivering top-qual...
About the Company : Since its founding in 1962, MOEHS has produced Active Pharmaceutical Ingredients (APIs) for the international pharmaceutical industry. Thanks to a business history of more than 50 ...
Zhejiang Hengkang Pharm Group is a dynamic pharmaceutical entity, spanning drug research, large-scale production, and global marketing.
About the Company : Established in 2004 and headquartered in Hangzhou, Hengkang established multiple factories, research and sales centers in Zhejiang, Shandong, and Henan. With facilities conforming ...
Zhejiang Hengkang Pharm Group is a dynamic pharmaceutical entity, spanning drug research, large-scale production, and global marketing.
About the Company : Established in 2004 and headquartered in Hangzhou, Hengkang established multiple factories, research and sales centers in Zhejiang, Shandong, and Henan. With facilities conforming ...
About the Company : BEC Chemicals Pvt. Ltd., was founded by Late Mr. M. T. Shah in 1979 and is specialized in manufacturing of Active pharmaceutical Ingredients (API’s) and Intermediates. The compan...
Regulatory Info :
Registration Country : Italy
Brand Name : Fluifort
Dosage Form :
Dosage Strength : 6 Monod Scir 10 Ml 2,7 G/10 Ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Fluifort
Dosage Form :
Dosage Strength : 30 Bust Grat 2,7 G
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Global Sales Information
Dosage Form :
Dosage Strength : 6 Monod Scir 10 Ml 2,7 G/10 Ml
Price Per Pack (Euro) : 8.1
Published in :
Country : Italy
RX/OTC/DISCN : Class C
Dosage Form :
Dosage Strength : 30 Bust Grat 2,7 G
Price Per Pack (Euro) : 20
Published in :
Country : Italy
RX/OTC/DISCN : Class C
Market Place
Reply
28 Oct 2024
Reply
21 Apr 2021
Reply
13 Oct 2020
Reply
12 Oct 2020
Reply
12 Mar 2019
Reply
08 Aug 2018
ABOUT THIS PAGE
77
PharmaCompass offers a list of Carbocysteine Lysine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Carbocysteine Lysine manufacturer or Carbocysteine Lysine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Carbocysteine Lysine manufacturer or Carbocysteine Lysine supplier.
PharmaCompass also assists you with knowing the Carbocysteine Lysine API Price utilized in the formulation of products. Carbocysteine Lysine API Price is not always fixed or binding as the Carbocysteine Lysine Price is obtained through a variety of data sources. The Carbocysteine Lysine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Carbocysteine Lysine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Carbocysteine Lysine, including repackagers and relabelers. The FDA regulates Carbocysteine Lysine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Carbocysteine Lysine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Carbocysteine Lysine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Carbocysteine Lysine supplier is an individual or a company that provides Carbocysteine Lysine active pharmaceutical ingredient (API) or Carbocysteine Lysine finished formulations upon request. The Carbocysteine Lysine suppliers may include Carbocysteine Lysine API manufacturers, exporters, distributors and traders.
click here to find a list of Carbocysteine Lysine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Carbocysteine Lysine written confirmation (Carbocysteine Lysine WC) is an official document issued by a regulatory agency to a Carbocysteine Lysine manufacturer, verifying that the manufacturing facility of a Carbocysteine Lysine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Carbocysteine Lysine APIs or Carbocysteine Lysine finished pharmaceutical products to another nation, regulatory agencies frequently require a Carbocysteine Lysine WC (written confirmation) as part of the regulatory process.
click here to find a list of Carbocysteine Lysine suppliers with Written Confirmation (WC) on PharmaCompass.
Carbocysteine Lysine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Carbocysteine Lysine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Carbocysteine Lysine GMP manufacturer or Carbocysteine Lysine GMP API supplier for your needs.
A Carbocysteine Lysine CoA (Certificate of Analysis) is a formal document that attests to Carbocysteine Lysine's compliance with Carbocysteine Lysine specifications and serves as a tool for batch-level quality control.
Carbocysteine Lysine CoA mostly includes findings from lab analyses of a specific batch. For each Carbocysteine Lysine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Carbocysteine Lysine may be tested according to a variety of international standards, such as European Pharmacopoeia (Carbocysteine Lysine EP), Carbocysteine Lysine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Carbocysteine Lysine USP).